Last reviewed · How we verify
NCT05575947
Comparative Analysis of da Vinci-Assisted and Laparoscopic Duodenal Switch Bariatric Surgical Procedures
trial testing da Vinci Surgical System in Bariatric Surgery Candidate in 1,878 participants. Completed in 22 September 2022.
22 September 2022
Quick facts
| Lead sponsor | Intuitive Surgical |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,878 |
| Start date | 1 May 2022 |
| Primary completion | 22 September 2022 |
| Estimated completion | 22 September 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- da Vinci Surgical System
- laparoscopic bariatric surgery
Conditions studied
- Bariatric Surgery Candidate — all drugs for Bariatric Surgery Candidate →
Sponsor
Intuitive Surgical — full company profile →
Who can join
18 and older, any sex, with Bariatric Surgery Candidate. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To compare the safety and effectiveness of robotic-assisted Duodenal-Switch Bariatric Surgical Procedures (including Biliopancreatic Diversion-Duodenal-Switch/BPD-DS, Single Anastomosis- Duodeno Ileal Bypass with Sleeve/SADI-S, and One Anastomosis Duodenal Switch/OADS) with laparoscopic approaches using real world data (RWD) from the Premier Healthcare Database (PHD).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05575947
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bariatric Surgery Candidate
Currently open trials in the same condition.
- NCT07525232 — Stepwise PEEP vs Sustained Inflation in Bariatric Surgery Patients · NA · recruiting
- NCT06511310 — Exercise, Brain Activity, and Weight Maintenance · NA · recruiting
- NCT05966727 — Exploratory Evaluation of the Effect of Cholestyramine on Serum Levels of POPs in Obese Female Patients · NA · recruiting
- NCT06915558 — Modulation of the Inflammatory Response in Bariatric Surgery · recruiting
- NCT06689241 — Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery · NA · recruiting
Other Intuitive Surgical trials
Trials by the same sponsor.
- NCT07346066 — IS-001 Injection in Patients Undergoing Robotic-Assisted Colorectal Surgery · Phase 3 · not yet recruiting
- NCT07259759 — JURA Study - Observational First-in-human Feasibility Study · completed
- NCT06434727 — Evaluating Intuitive 3D Models in Preoperative Surgical Planning for Thoracic and Colorectal Procedures. · completed
- NCT06308120 — A Trial to Compare Robotic Assisted Bronchoscopy Ion's Clinical Utility for Peripheral Lung Nodule Access and Diagnosis · NA · active not recruiting
- NCT05954767 — IS-001 Injection in Patients Undergoing Robotic-Assisted Gynecological Surgery · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05575947 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Intuitive Surgical
- Last refreshed: 29 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05575947.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing